Regulus Therapeutics Inc.
RGLS · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$46 | -$30 | -$28 | -$28 |
| Dep. & Amort. | -$1 | $0 | $0 | $0 |
| Deferred Tax | $0 | $0 | $0 | -$1 |
| Stock-Based Comp. | $8 | $3 | $2 | $3 |
| Change in WC | -$2 | $0 | $1 | $1 |
| Other Non-Cash | $0 | -$0 | -$0 | $0 |
| Operating Cash Flow | -$42 | -$27 | -$26 | -$24 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$0 | -$1 | -$0 | -$0 |
| Net Acquisitions | $0 | $0 | $0 | $0 |
| Inv. Purchases | -$84 | -$5 | -$33 | $0 |
| Inv. Sales/Matur. | $48 | $20 | $18 | $0 |
| Other Inv. Act. | $0 | $0 | -$0 | $0 |
| Investing Cash Flow | -$36 | $14 | -$15 | -$0 |
| Financing Activities | – | – | – | – |
| Debt Repay. | -$1 | -$3 | $0 | -$0 |
| Stock Issued | $94 | $15 | $4 | $54 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | $0 | $0 | $0 | $0 |
| Financing Cash Flow | $92 | $12 | $4 | $54 |
| Forex Effect | $0 | $0 | $0 | $0 |
| Net Chg. in Cash | $15 | -$0 | -$36 | $29 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $24 | $24 | $60 | $31 |
| End Cash | $39 | $24 | $24 | $60 |
| Free Cash Flow | -$42 | -$27 | -$26 | -$24 |